Here’s whether Medtronic plc (MDT) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.10% over 10 days); RSI 50 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend). Currently 21.7% off its 52-week high. Score: +1/7.
MDT is trading below its 200-day MA ($90.38) — a key warning sign the longer-term trend is under pressure. An RSI of 50.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -9.9% compares to +16.5% for SPY (trailed the market by 26.3%). The current 21.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $9,013 today
vs. S&P 500 (SPY) — same period trailed market by 26.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($90.38)
✓Above 50-day MA ($79.92)
✓RSI(14) neutral zone (30–70) — currently 50.5
✗Positive return (-9.9%)
!Within 10% of period high (−21.7%)
Period Range $83.21
$73.31$106.33
RSI (14) 50.5
0 · OversoldOverbought · 100
Key Metrics
Price$83.21
Period Return-9.9%
Period High$106.33
Period Low$73.31
Drawdown−21.7%
MA-50$79.92
MA-200$90.38
RSI (14)50.5
Avg Volume (30d)8.6M
vs. SPYtrailed by 26.3%
Return Rank#610 of 999
Trend Signals
Price is below the 200-day moving average ($90.38)